Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
31.3 EUR | +0.81% | -1.72% | -25.96% |
Apr. 04 | DERMAPHARM : Berenberg keeps its Buy rating | ZD |
Mar. 28 | Dermapharm Holding SE Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 1.17B 1.25B | Sales 2025 * | 1.22B 1.31B | Capitalization | 1.67B 1.79B |
---|---|---|---|---|---|
Net income 2024 * | 112M 120M | Net income 2025 * | 130M 139M | EV / Sales 2024 * | 2.13 x |
Net Debt 2024 * | 812M 871M | Net Debt 2025 * | 699M 749M | EV / Sales 2025 * | 1.94 x |
P/E ratio 2024 * |
14.9
x | P/E ratio 2025 * |
12.9
x | Employees | 3,497 |
Yield 2024 * |
3.39% | Yield 2025 * |
3.87% | Free-Float | 32.26% |
1 day | +0.48% | ||
1 week | -2.36% | ||
Current month | -4.87% | ||
1 month | -6.81% | ||
3 months | -18.67% | ||
6 months | -18.20% | ||
Current year | -26.67% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 61 | 17-07-31 | |
Director of Finance/CFO | - | 22-10-31 | |
Britta Hamberger
IRC | Investor Relations Contact | - | 18-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 75 | 17-12-31 | |
Wilhelm Beier
CHM | Chairman | 68 | 17-07-31 |
Erwin Kern
BRD | Director/Board Member | 63 | 17-07-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.01% | 125 M€ | -.--% | ||
0.73% | 17 M€ | -.--% | - | |
0.16% | 79 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 31.35 | +0.97% | 25 998 |
24-04-25 | 31.05 | -1.43% | 22,157 |
24-04-24 | 31.5 | -3.08% | 34,510 |
24-04-23 | 32.5 | -0.61% | 22,522 |
24-04-22 | 32.7 | +2.51% | 32,788 |
Delayed Quote Xetra, April 25, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.67% | 1.79B | |
+24.17% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+13.45% | 233B | |
+6.04% | 201B | |
-10.51% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |
- Stock Market
- Equities
- DMP Stock